Insmed is rated a hold, reflecting a robust therapeutic pipeline but persistent unprofitability, and is priced at a high ...

Discover 10 undervalued healthcare stocks and why pharmaceuticals and providers stand out for value and quality.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge funds betting on drugs stocks have made bumper profits this year, as a recent wave of deals by big ...

CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in single-use bioreactor technology, today announced the launch of MiniPRO™, a multi-parallel Vertical-Wheel ® bioreactor ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Reader, beware: You’re entering haunted grounds. Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're embracing the spooky spirit of ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

Over the last two weeks, companies have unveiled enhanced panel design capabilities for spectral flow cytometry and same-cell RNA and protein analysis for the advancement of spatial biology. We’ve ...